Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailPrenetics CEO discusses $200 million JV for early cancer detectionDanny Yeung, CEO of Hong Kong's genetics testing firm Prenetics, speaks about the $200 million joint venture that his company has formed with professor Dennis Lo from Chinese University of Hong Kong, who pioneered non-invasive prenatal testing. The joint venture will focus on blood tests for early cancer detection.

---

Persons: Danny Yeung, Dennis Lo Organizations: JV, University of Hong Locations: University of Hong Kong